VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+150.07%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$389M
AUM Growth
+$389M
(+107%)
Cap. Flow
-$275K
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
|
$275K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZB
1
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $321M | 82.47% | 5,158,161 | – | – |
|
2
CRISPR Therapeutics
CRSP
$4.71B
| $31.2M | 8.03% | 498,558 | – | – |
|
3
Repare Therapeutics
RPTX
$71.7M
| $19.3M | 4.97% | 2,646,657 | – | – |
|
|
GRTS
4
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $7.26M | 1.87% | 3,561,150 | – | – |
|
5
Passage Bio
PASG
$22.7M
| $5.01M | 1.29% | 4,959,769 | – | – |
|
6
Adverum Biotechnologies
ADVM
$64.6M
| $3.82M | 0.98% | 5,068,233 | – | – |
|
7
Aligos Therapeutics
ALGS
$73.3M
| $1.54M | 0.4% | 2,320,381 | – | – |
|
|
UTRS
8
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| – | – | -83,684 | Closed | -$275K |
|